Safety and Efficacy of Intravesical Botulinum Toxin in TC-3 Gel in OAB Patients

Clinical trial NCT02179099 · TERMINATED

Trial details

NCT number: NCT02179099
Sponsor: UroGen Pharma Ltd.
Status: TERMINATED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Overactive Bladder

Start date: 2014-07-01
Primary completion: 2015-11-01
Enrollment: 3

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.